Public Company News
Weibo Announces Results of 2022 Annual General Meeting
BEIJING, June 6, 2022 /PRNewswire/ -- Weibo Corporation ("Weibo" or the "Company") (NASDAQ: WB and HKEX: 9898), a leading social media inChina, today announced that the following proposed resolutions submitted for shareholder approval have been adopted at its 2022 annual general meeting of shareh...
2022-06-06 17:00
3689
"Captain Tsubasa: Dream Team" 5th Anniversary Kicks Off & New Players Wearing the JUVENTUS Official Kit Debut
TOKYO, June 6, 2022 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that its head-to-head football simulation gameCaptain Tsubasa: Dream Teamkicked off its special 5th Anniversary with the JUVENTUS OFFICIAL CAMPAIGN: Gifts for All and more in-game campaigns onFriday, June 3....
2022-06-06 15:15
3073
CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer
* The National Medical Products Administration approved sugemalimab for the treatment of patients with unresectable stage III non-small cell lung cancer whose disease has not progressed following concurrent or sequential platinum-based chemoradiotherapy * Sugemalimab became the first anti-PD-...
2022-06-06 12:23
3360
iQIYI Showcases Technology-Enabled Green Production Techniques on World Environment Day
BEIJING, June 6, 2022 /PRNewswire/ -- On Jun. 5, iQIYI, an innovative market-leading online entertainment service inChina, shared its commitment to a sustainable future on World Environment Day, a day where businesses, communities, and governments around the world come together to raise awareness...
2022-06-06 12:20
6818
Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) combined with chemotherapy in advanced NSCLC at ASCO 2022
HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster discussion featuring a phase II ...
2022-06-06 09:00
2515
Akeso announces oral presentation featuring promising clinical data of Cadonilimab (PD-1/CTLA-4 BsAbs, AK104) for the first-line treatment of R/M cervical cancer at ASCO 2022
HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released updated results of Cadonilimab (PD-1/CTLA-4 Bispecific, AK...
2022-06-06 09:00
2390
Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) for advanced NSCLC at ASCO 2022
HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster presentation featuring phase Ib...
2022-06-06 09:00
2611
Pepper Money's SOLANA Improves Business Volumes by 70% with the Appian Low-Code Platform
SYDNEY, June 6, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) announced today that Pepper Money, a leading consumer finance company inAustralia is using the Appian Low-Code Platform to support its Asset Finance Loan Origination solution, SOLANA, which has allowed the company to grow its business vol...
2022-06-06 07:00
4481
Recon Receives NASDAQ Notification Regarding Minimum Bid Requirements
BEIJING, June 3, 2022 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company") today announced that onJune 1, 2022, it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is currently not in compliance with the minimum bid price requ...
2022-06-04 04:30
7126
Dogness (International) Corporation Closes $12 Million Offering
DONGGUAN, China, June 3, 2022 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced that it closed a previously announced offerin...
2022-06-04 01:48
8857
Dada Group's JDDJ fulfilled the first order in JD618 Grand Promotion, and saw sales surge
SHANGHAI, June 3, 2022 /PRNewswire/ -- On May 31, only 10 minutes after the official opening of JD618 Grand Promotion, one consumer who lives in Chaoyang District,Beijing, had received the milk powder and kid toys she bought from JDDJ. These products labeled with "Shop Now", are supported by Dada...
2022-06-03 23:45
7940
Gracell Biotechnologies Schedules Clinical Update Call After EHA2022
SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, June. 3, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today a...
2022-06-03 23:00
7136
ASIP Tech selected by Wizz Air for free inflight connectivity
NEW YORK, June 3, 2022 /PRNewswire/ -- AS-IP Tech (USOTC: IPTK) announced today it has signed an agreement with Wizz Air (LSE: WIZZ) to provide connectivity on its fleet of A320 and A321 UK based aircraft. In a world first, Wizz Air will integrate AS-IP Tech's fflya Bluetooth platform into its m...
2022-06-03 22:00
7174
JX Luxventure receives Nomination for the "Best Software Solution Provider" Award
HAIKOU, China, June 3, 2022 /PRNewswire/ -- JX Luxventure Limited (Nasdaq: LLL) (the "Company"), a company delivering comprehensive products solutions to global elite families serviced by our business customers with business segments covering menswear, cross-border merchandise and tourism, announ...
2022-06-03 21:36
9453
ProSomnus® to Present Data at SLEEP 2022, the Annual Meeting of the American Academy of Sleep Medicine and the Sleep Research Society
SAN FRANCISCO, June 3, 2022 /PRNewswire/ -- ProSomnus, a leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the results of three studies evaluating its FDA-cleared Oral Appliance Therapy (OAT) devices in the treatment of OSA. ProSomnus ...
2022-06-03 20:00
7749
KAZIA PRESENTS POSITIVE FINAL DATA FROM PHASE II STUDY OF PAXALISIB IN NEWLY DIAGNOSED GLIOBLASTOMA AT ASCO CONFERENCE
SYDNEY, June 3, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce final data from its phase II study of paxalisib as first line therapy in patients with glioblastoma (NCT03522298). The data is the subj...
2022-06-03 19:00
9914
CANACCORD GENUITY GROUP INC. REPORTS FOURTH QUARTER AND FISCAL 2022 RESULTS
Excluding significant items, quarterly earnings per common share of $0.52 (1) Excluding significant items, record full fiscal year earnings per common share of$2.51 (1) Fiscal 2022 common share year dividend payout increased 28% year-over-year TORONTO, June 3, 2022 /PRNewswire/ -- Canaccord Genuit...
2022-06-03 08:25
3749
XCMG's XGT15000-600S, the World's Largest Tower Crane, Rolls Off the Assembly Line
XUZHOU, China, June 2, 2022 /PRNewswire/ -- The XGT15000-600S, the world's largest tower crane jointly developed by XCMG (SHE:000425) and China Major Bridge Engineering Co., Ltd. (MBEC), has rolled off the assembly line on today. The model was designed and put into production to meet the increa...
2022-06-02 23:54
4458
HD Hyundai's Avikus successfully conducts the world's first transoceanic voyage of a large merchant ship relying on autonomous navigation technologies
* On June 2, SK Shipping's super-large LNG carrier arrived at a South Korean port after a month-long transoceanic voyage. * The vessel equipped with HD Hyundai's Avikus-developed HiNAS 2.0, Level 2 autonomous navigation solution, was successfully operated over 10,000 km. * HiNAS 2.0 creates ...
2022-06-02 21:00
3186
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy
Multiple System Atrophy is a rare, rapidly progressive, neurodegenerative disease that causes profound disability MELBOURNE, Australia, June 2, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disea...
2022-06-02 20:00
3460
Week's Top Stories
Most Reposted
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 295 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 284 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 282 media titles]
2026-10-15 12:59
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 269 media titles]
2026-10-21 15:00
Most Read
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
28284
Agoda and Emerging Travel Group Enter Strategic Partnership
2026-10-15 16:00
17907